A carregar...
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases
AIM: To assess clinical and endoscopic response to propionyl-L-carnitine hydrochloride (PLC) in colonic inflammatory bowel disease. METHODS: Patients suffering from mild to moderate ulcerative colitis (UC) or Crohn’s disease (CD) colitis, with disease activity index (DAI) between 3 and 10 and under...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Co., Limited
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3460333/ https://ncbi.nlm.nih.gov/pubmed/23049215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i36.5065 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|